Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

JDRF

- PMLiVE

GSK submits albiglutide for European approval

If approved the diabetes drug will be launched as Eperzan

- PMLiVE

UK doctors get online patient access guidance

RCGP looks at practicalities of giving patients online access to records and services

Is pharma applying digital quickly enough?

In a guest blog, Alex Butler looks at digital changes, and how pharma can learn from other industries

- PMLiVE

FDA approves J&J’s Bluetooth blood glucose monitor

Licenses iPhone, iPad and iPod Touch compatible monitoring system

- PMLiVE

Novo’s Lantus rival Tresiba hits European markets

Company says its insulin degludec is a more flexible alternative to Sanofi's product

- PMLiVE

Sanofi gets EMA backing for multi-disease vaccine in children

Hexyon-Hexacima 6-in-1 paediatric vaccine recommended for approval in Europe

- PMLiVE

Online tycoons announce first winners of $33m research prize

Billionaire founders of Facebook and Google among those behind Breakthrough Prize in Life Sciences

- PMLiVE

The game changer: Gaming in healthcare

How gaming can affect health, from improving lifestyle habits and behaviour modification, to self-management, through to motivating and supporting physical activity

Sanofi reception

FDA to review Sanofi’s lixisenatide for diabetes

Follows drug's European approval under brand name Lyxumia earlier this month

- PMLiVE

Genzyme on track for eliglustat filing in 2013

Says oral Gaucher disease drug as effective as its injectable Cerezyme

Why digital healthcare means strategy is now vital

Thought Leader: Going digital means that the process of proper planning of both messages and campaigns is once again useful in healthcare

- PMLiVE

FDA turns down Novo Nordisk’s Tresiba and Ryzodeg

Decision could delay the US launch of the diabetes drugs by two years or more

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links